Correlation Between BB Biotech and Schweiter Technologies

Can any of the company-specific risk be diversified away by investing in both BB Biotech and Schweiter Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Schweiter Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BB Biotech AG and Schweiter Technologies AG, you can compare the effects of market volatilities on BB Biotech and Schweiter Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Schweiter Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Schweiter Technologies.

Diversification Opportunities for BB Biotech and Schweiter Technologies

0.72

Correlation Coefficient

BB Biotech  Schweiter Technologies

Poor diversification

The 3 months correlation between BION and Schweiter is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Schweiter Technologies AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Schweiter Technologies and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Schweiter Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Schweiter Technologies has no effect on the direction of BB Biotech i.e., BB Biotech and Schweiter Technologies go up and down completely randomly.

Pair Corralation between BB Biotech and Schweiter Technologies

Assuming the 90 days trading horizon BB Biotech AG is expected to generate 0.94 times more return on investment than Schweiter Technologies. However, BB Biotech AG is 1.06 times less risky than Schweiter Technologies. It trades about 0.15 of its potential returns per unit of risk. Schweiter Technologies AG is currently generating about 0.12 per unit of risk. If you would invest  2,845  in BB Biotech AG on April 23, 2025 and sell it today you would earn a total of  405.00  from holding BB Biotech AG or generate 14.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

BB Biotech AG  vs.  Schweiter Technologies AG

BB Biotech AG

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in BB Biotech AG are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, BB Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Schweiter Technologies

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Schweiter Technologies AG are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Schweiter Technologies may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with BB Biotech and Schweiter Technologies

The main advantage of trading using opposite BB Biotech and Schweiter Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Schweiter Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Schweiter Technologies will offset losses from the drop in Schweiter Technologies' long position.

The idea behind BB Biotech AG and Schweiter Technologies AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.